Point‑of‑care diagnostics market set to reach $31.5 billion by 2031, growing at 8.8% CAGR according to MarketsandMarkets
Executive summary: MarketsandMarkets projects the point‑of‑care diagnostics market to grow from about USD 20.63 billion in 2026 to USD 31.46 billion by 2031, reflecting a compound annual growth rate of 8.8%. The projected expansion signals increasing demand for rapid, decentralized testing, which could spur higher capital allocation to diagnostics manufacturers and influence healthcare spending patterns.
Who is involved: MarketsandMarkets (research publisher), point‑of‑care diagnostics companies, healthcare providers, investors, and regulatory bodies.
Likely next: Continued product innovation, pursuit of regulatory clearances for new POCT devices, and potential merger‑and‑acquisition activity as the market expands.
The MarketsandMarkets report highlights a steady expansion of the point‑of‑care diagnostics market, driven by rising demand for rapid testing and decentralized healthcare. An 8.8% CAGR suggests the sector will add roughly $10.8 billion in value over five years, attracting investment from both established medical‑device firms and new entrants. While the forecast is based on current trends, actual outcomes will depend on regulatory approvals, technology adoption rates, and reimbursement policies.
Timeline
- — Point of Care Diagnostics Market worth $31.46 billion by 2031 | MarketsandMarkets™ (PR Newswire)
- — 3D Sensor Market worth $21.45 billion by 2032 - Exclusive Report by MarketsandMarkets™ (PR Newswire)
Analysis — what this means
Sectors affected
- Point-of-care diagnostics
Key entities
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped